1. 218PAutoimmunity and benefit from trastuzumab treatment in breast cancer: Results from the HERA phase III trial. (23rd October 2018) Authors: Sonnenblick, A; Bailey, A; Uziely, B; Untch, M; Smith, I; Gianni, L; Baselga, J; Jackisch, C; Cameron, D; Bell, R; Zardavas, D; Al-Sakaff, N; Gelber, R; Dowsett, M; Leyland-jones, B; Piccart, M; de Azambuja, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗